January 6, 2017
India’s Natco cleared to sell generic version of Teva’s leukemia treatment Trenda in USA
Indian drugmaker Natco Pharma has gotten the approval from the U.S. regulator for generic version of Teva’s leukemia treatment Trenda (Bendamustine Hydrochloride powder for Injection).